| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Komasinski Michael | CEO, Director | C/O CRITEO LEGAL DEPT., 387 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK | /s/ Ryan Damon, as attorney-in-fact for Michael Komasinski | 02 Mar 2026 | 0002056554 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRTO | Ordinary Shares | Award | $0 | +42,771 | +24% | $0.000000 | 219,406 | 26 Feb 2026 | Direct | F1, F2, F3 |
| Id | Content |
|---|---|
| F1 | The Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share. |
| F2 | On February 28, 2025, the Reporting Person was granted performance-based stock units representing 60,241 shares of the Issuer at the target performance level, which would become eligible to vest based on the achievement of performance goals. On February 26, 2026, the achievement percentage was determined, resulting in 42,771 shares becoming eligible to time-based vesting as follows: two thirds of the shares will vest on the two year anniversary of the grant date, and the remainder of the shares will vest on the three year anniversary of the grant date |
| F3 | For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. |